Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1226 | 2679 | 35.0 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
36 | 32479 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL INTRAEPITHELIAL NEOPLASIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HPV VACCINE | Author keyword | 327 | 72% | 10% | 259 |
2 | HPV VACCINATION | Author keyword | 135 | 66% | 5% | 124 |
3 | HUMAN PAPILLOMAVIRUS VACCINE | Author keyword | 88 | 68% | 3% | 76 |
4 | HUMAN PAPILLOMAVIRUS | Author keyword | 73 | 11% | 22% | 600 |
5 | PAPILLOMAVIRUS VACCINES | Author keyword | 71 | 72% | 2% | 55 |
6 | HPV VACCINES | Author keyword | 56 | 64% | 2% | 54 |
7 | GENITAL WARTS | Author keyword | 44 | 35% | 4% | 102 |
8 | HPV | Author keyword | 42 | 11% | 14% | 375 |
9 | HUMAN PAPILLOMAVIRUS HPV VACCINE | Author keyword | 34 | 93% | 0% | 13 |
10 | HPV 16 18 AS04 ADJUVANTED VACCINE | Author keyword | 30 | 100% | 0% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HPV VACCINE | 327 | 72% | 10% | 259 | Search HPV+VACCINE | Search HPV+VACCINE |
2 | HPV VACCINATION | 135 | 66% | 5% | 124 | Search HPV+VACCINATION | Search HPV+VACCINATION |
3 | HUMAN PAPILLOMAVIRUS VACCINE | 88 | 68% | 3% | 76 | Search HUMAN+PAPILLOMAVIRUS+VACCINE | Search HUMAN+PAPILLOMAVIRUS+VACCINE |
4 | HUMAN PAPILLOMAVIRUS | 73 | 11% | 22% | 600 | Search HUMAN+PAPILLOMAVIRUS | Search HUMAN+PAPILLOMAVIRUS |
5 | PAPILLOMAVIRUS VACCINES | 71 | 72% | 2% | 55 | Search PAPILLOMAVIRUS+VACCINES | Search PAPILLOMAVIRUS+VACCINES |
6 | HPV VACCINES | 56 | 64% | 2% | 54 | Search HPV+VACCINES | Search HPV+VACCINES |
7 | GENITAL WARTS | 44 | 35% | 4% | 102 | Search GENITAL+WARTS | Search GENITAL+WARTS |
8 | HPV | 42 | 11% | 14% | 375 | Search HPV | Search HPV |
9 | HUMAN PAPILLOMAVIRUS HPV VACCINE | 34 | 93% | 0% | 13 | Search HUMAN+PAPILLOMAVIRUS+HPV+VACCINE | Search HUMAN+PAPILLOMAVIRUS+HPV+VACCINE |
10 | HPV 16 18 AS04 ADJUVANTED VACCINE | 30 | 100% | 0% | 12 | Search HPV+16+18+AS04+ADJUVANTED+VACCINE | Search HPV+16+18+AS04+ADJUVANTED+VACCINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PARTICLE VACCINE | 397 | 52% | 20% | 538 |
2 | HUMAN PAPILLOMAVIRUS VACCINATION | 396 | 77% | 10% | 270 |
3 | HPV VACCINE | 331 | 76% | 9% | 234 |
4 | HPV VACCINATION | 302 | 72% | 9% | 239 |
5 | HUMAN PAPILLOMAVIRUS VACCINE | 246 | 71% | 8% | 201 |
6 | QUADRIVALENT VACCINE | 191 | 59% | 8% | 215 |
7 | SUSTAINED EFFICACY | 145 | 59% | 6% | 162 |
8 | PARENTAL ACCEPTANCE | 122 | 86% | 2% | 62 |
9 | AGED 13 17 YEARS | 110 | 75% | 3% | 79 |
10 | PEDIATRICIANS INTENTION | 102 | 95% | 1% | 35 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Barriers to Human Papillomavirus Vaccination Among US Adolescents A Systematic Review of the Literature | 2014 | 41 | 69 | 94% |
Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review | 2015 | 6 | 40 | 98% |
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines | 2012 | 128 | 75 | 69% |
Human Papillomavirus Vaccine Introduction - The First Five Years | 2012 | 76 | 36 | 97% |
Factors associated with HPV vaccine uptake in teenage girls: A systematic review | 2012 | 76 | 52 | 92% |
Global Burden of Human Papillomavirus and Related Diseases | 2012 | 160 | 37 | 41% |
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis | 2012 | 79 | 32 | 56% |
Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes | 2013 | 29 | 71 | 86% |
Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis | 2011 | 85 | 26 | 73% |
Acceptability of Human Papillomavirus Vaccine for Males: A Review of the Literature | 2010 | 70 | 31 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HPV VACCINAT PROGRAM REGISTER | 30 | 100% | 0.4% | 12 |
2 | DIAGNOST TREATMENT SEXUALLY TRANSMITTED DIS | 21 | 85% | 0.4% | 11 |
3 | FAMILY MED OBSTET GYNECOL | 17 | 75% | 0.4% | 12 |
4 | EPIDEMIOL HIV STD UNIT | 15 | 73% | 0.4% | 11 |
5 | GRP SALUDCOOP | 12 | 86% | 0.2% | 6 |
6 | ADOLESCENT BEHAV HLTH | 8 | 45% | 0.5% | 14 |
7 | IMMUNIZAT SERV | 8 | 16% | 1.8% | 47 |
8 | RURAL CANC PREVENT | 7 | 64% | 0.3% | 7 |
9 | SP POS | 6 | 80% | 0.1% | 4 |
10 | STIFTUNG JULIUSSPITAL | 6 | 58% | 0.3% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160359 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER |
2 | 0.0000120169 | VISUAL INSPECTION WITH ACETIC ACID//CERVICOGRAPHY//SCREENING GRP |
3 | 0.0000112043 | CELLULAR ONCOL//EMMY NOETHER GRP VIRUS ENDOCYTOSIS//PAPILLOMAVIRUS |
4 | 0.0000097019 | CERVICAL SCREENING//CERVICAL CANCER SCREENING//NSW CERV SCREENING PROGRAM |
5 | 0.0000081536 | IMMUNIZAT PROGRAM//IMMUNIZATION//VACCINE HESITANCY |
6 | 0.0000061813 | NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG//IMMUNIZATION FINANCING//PROVAC INITIAT |
7 | 0.0000055359 | CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS//HIV IN WOMEN//CERVICAL DYSPLASIA |
8 | 0.0000053600 | ANAL CANCER//ANAL INTRAEPITHELIAL NEOPLASIA//ANAL CARCINOMA |
9 | 0.0000051040 | CONDYLOMATA ACUMINATA//GENITAL WARTS//PENISCOPY |
10 | 0.0000039792 | HIV VACCINE TRIALS//HIV VACCINES//WILLINGNESS TO PARTICIPATE |